ClinicalTrials.gov
public full text
Public Domain
TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Colorectal Cancer, Liver Metastases and Biotherapies#364055
- Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer#804982
- Neoadjuvant Triple Therapy for Resectable HCC#899025
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer#979412
- CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer#411296
Record · ID 238096
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive